Hong-Fang Fu (Hongfang Fu)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Systematic Review

Estrogen Receptor

Top Venues

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Hong-Fang Fu, Weiwei Hou, Yang Zhang, Xiaoyu Hu
Alprostadil for hypertensive nephropathy: A systematic review and meta-analysis of randomized controlled trials. PloS one 17 (5) (2022)
Yang Zhang, Jian-Xing Luo, Yan-Ge Li, Hong-Fang Fu, Fang Yang, Xiao-Yu Hu
An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Yilan Wang, Xiaomin Wang, Hong-Fang Fu, Shuo Kou, Demei Huang, Zherui Shen, Fei Wang, Zhenxing Wang
Yunnan Baiyao Adjuvant Treatment for Patients with Hemoptysis: A Systematic Review and Meta-Analysis. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Hong-Fang Fu, Yilan Wang, Haoyue Feng, Yang Zhang, Xiao-Yu Hu
Qijiaoshengbai Capsule for Leukopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)